Autolus Therapeutics plc
AUTL- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001730463
In the last 90 days, Autolus Therapeutics plc insiders filed 0 open-market purchases and 1 sale; 83 institutions reported holding it in 13F filings for Q2 2026, worth $212.0M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Autolus Therapeutics plc changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Of which not filed for Q3 2022 | Q3 2022 | Change |
|---|---|---|---|---|
| Holders | 67 | 1 | 66 | 0 |
| Shares | 50.8M | 180 | 49.4M | −1.46M (−2.9%) |
| Value | $143.9M | $509 | $105.7M | −$38.2M (−26.5%) |
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (7)
Institutions that held Autolus Therapeutics plc at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Kettle Hill Capital Management, LLC | 89,792 | $192.0K | 0.05% |
| LPL Financial LLC | 23,200 | $50.0K | 0.00% |
| Gsa Capital Partners LLP | 22,885 | $49.0K | 0.01% |
| US Bancorp | 7,652 | $16.0K | 0.00% |
| Quadrant Capital Group LLC | 921 | $2.00K | 0.00% |
| China Universal Asset Management Co., Ltd. | 542 | $1.00K | 0.00% |
| State of Wyoming | 51 | $0 | 0.00% |
Sold out (7)
Institutions that held Autolus Therapeutics plc at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Acadian Asset Management LLC | 34,888 | $98.0K |
| Total Clarity Wealth Management, Inc. | 1,200 | $3.00K |
| Northwestern Mutual Wealth Management Co | 500 | $1.00K |
| Captrust Financial Advisors | 500 | $1.00K |
| Lindbrook Capital, LLC | 177 | $1.00K |
| Cutler Group LP | 100 | $0 |
| Curi Capital | 137 | $0 |
Not filed for Q3 2022 yet (1)
Institutions that held Autolus Therapeutics plc at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Exane Derivatives | 180 | $509 |